Revenue: The sum of all revenue fields included for a company's operating activities.
Tango Therapeutics, Inc. (TNGX) had Revenue of $5.39M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$5.39M |
$-39.88M |
|
-- |
|
$5.39M |
|
$47.92M |
|
$-42.53M |
|
$2.69M |
|
$-39.84M |
|
$-39.84M |
|
$-39.88M |
|
$-39.88M |
|
$-39.88M |
|
$-39.88M |
|
$-42.53M |
|
$-42.55M |
|
110.30M |
|
110.30M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$224.93M |
|
$7.54M |
|
$49.38M |
|
$274.31M |
|
$35.92M |
|
-- |
|
$71.63M |
|
$107.55M |
|
$166.76M |
|
$166.76M |
|
$166.76M |
|
108.11M |
|
| Cash Flow Statement Financials | |
$-41.70M |
|
$30.60M |
|
$0.00M |
|
$72.10M |
|
$61.00M |
|
$-11.10M |
|
$7.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-788.76% |
|
-788.76% |
|
-- |
|
-738.91% |
|
-739.54% |
|
$-41.75M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-23.91% |
|
-23.91% |
|
-14.54% |
|
-23.91% |
|
$1.54 |
|
$-0.38 |
|
$-0.38 |
|